BRIEF-Astrazeneca and Peregrine Pharma to collaborate on immuno-oncology combination clinical trial By: Reuters: Company News August 24, 2015 at 02:42 AM EDT * Astrazeneca and Peregrine Pharmaceuticals to collaborate on immuno-oncology combination clinical trial Read More >> Related Stocks: Astrazeneca Plc ADR